JNJ vs. HIMS
JNJ (Johnson & Johnson) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — JNJ in Drug Manufacturers - General, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, JNJ returned 10.94%/yr vs 17.04%/yr for HIMS. At a correlation of -0.01, they often move in opposite directions.
Performance
JNJ vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JNJ achieves a 17.68% return, which is significantly higher than HIMS's -17.40% return.
JNJ
- 1D
- 1.07%
- 1M
- 4.96%
- YTD
- 17.68%
- 6M
- 15.11%
- 1Y
- 57.15%
- 3Y*
- 17.82%
- 5Y*
- 10.94%
- 10Y*
- 10.46%
HIMS
- 1D
- -7.10%
- 1M
- 10.64%
- YTD
- -17.40%
- 6M
- -27.92%
- 1Y
- -51.66%
- 3Y*
- 43.69%
- 5Y*
- 17.04%
- 10Y*
- —
JNJ vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 17.68% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 12.61% |
HIMS Hims & Hers Health, Inc. | -17.40% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between JNJ and HIMS is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | -0.01 |
The correlation between JNJ and HIMS shifts across timeframes, from -0.15 (1 year) to -0.01 (all time), reflecting how their relationship changes across market environments.
Fundamentals
JNJ:
$588.98B
HIMS:
$6.12B
JNJ:
$8.65
HIMS:
-$0.05
JNJ:
6.08
HIMS:
2.78
JNJ:
7.25
HIMS:
13.73
JNJ:
$96.36B
HIMS:
$2.37B
JNJ:
$66.60B
HIMS:
$1.70B
JNJ:
$31.62B
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JNJ vs. HIMS — Risk / Return Rank
JNJ
HIMS
JNJ vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JNJ | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.97 | ||
| Sortino ratioReturn per unit of downside risk | +5.39 | ||
| Omega ratioGain probability vs. loss probability | 1.61 | 0.95 | +0.67 |
| Calmar ratioReturn relative to maximum drawdown | 5.28 | -0.68 | +5.96 |
| Martin ratioReturn relative to average drawdown | 15.52 | -1.10 | +16.63 |
Loading charts...
Drawdowns
JNJ vs. HIMS - Drawdown Comparison
The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for JNJ and HIMS.
Loading charts...
Drawdown Indicators
| JNJ | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.67% | -87.29% | +36.62% |
Max Drawdown (1Y)Largest decline over 1 year | -10.96% | -78.06% | +67.10% |
Max Drawdown (3Y)Largest decline over 3 years | -15.95% | -78.88% | +62.93% |
Max Drawdown (5Y)Largest decline over 5 years | -18.41% | -78.88% | +60.47% |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | — | — |
Current DrawdownCurrent decline from peak | -2.54% | -60.98% | +58.44% |
Average DrawdownAverage peak-to-trough decline | -11.90% | -43.23% | +31.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.72% | 48.06% | -44.34% |
Volatility
JNJ vs. HIMS - Volatility Comparison
The current volatility for Johnson & Johnson (JNJ) is 5.47%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 21.36%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JNJ | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.47% | 21.36% | -15.89% |
Volatility (6M)Calculated over the trailing 6-month period | 12.16% | 67.20% | -55.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.94% | 96.46% | -79.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.87% | 83.26% | -66.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.48% | 77.20% | -58.72% |
Dividends
JNJ vs. HIMS - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 2.18%, while HIMS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
JNJ vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. HIMS - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
JNJ and HIMS have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (21.36%) compared to JNJ (5.47%). In terms of maximum drawdown, JNJ dropped -50.67% vs HIMS's -87.29%.
JNJ currently has the higher Sharpe Ratio (3.42 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JNJ and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer